Cargando…

Indications and patterns of use of benzodiazepines and opioids in severe interstitial lung disease: a population-based longitudinal study

BACKGROUND: Despite evidence that opioids might relieve chronic breathlessness, physicians may still be reluctant to prescribe them due to safety concerns. By contrast, benzodiazepine (BDZ) prescribing often seeks to reduce chronic breathlessness despite no evidence of net benefit. Prescribing patte...

Descripción completa

Detalles Bibliográficos
Autores principales:	Genberg, Jenny, Davies, Joanna M., Ahmadi, Zainab, Currow, David, Johnson, Miriam J., Tanash, Hanan, Bajwah, Sabrina, Ekström, Magnus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7861020/ https://www.ncbi.nlm.nih.gov/pubmed/33569492 http://dx.doi.org/10.1183/23120541.00716-2020

Ejemplares similares

Safety of benzodiazepines and opioids in very severe respiratory disease: national prospective study
por: Ekström, Magnus P, et al.
Publicado: (2014)

Prescription of opioids for breathlessness in end-stage COPD: a national population-based study
por: Ahmadi, Zainab, et al.
Publicado: (2016)

The risk of burn injury during long-term oxygen therapy: a 17-year longitudinal national study in Sweden
por: Tanash, Hanan A, et al.
Publicado: (2015)

Lung transplantation and survival outcomes in patients with oxygen-dependent COPD with regard to their alpha-1 antitrypsin deficiency status
por: Ekström, Magnus, et al.
Publicado: (2017)

Is it safe to prescribe benzodiazepines or opioids for dyspnoea in interstitial lung disease?
por: Finney, Lydia J.
Publicado: (2019)

Symptom prevalence of patients with fibrotic interstitial lung disease: a systematic literature review
por: Carvajalino, Sabrina, et al.
Publicado: (2018)

Can variability in the effect of opioids on refractory breathlessness be explained by genetic factors?
por: Currow, David C, et al.
Publicado: (2015)

Risk of cancer after lung transplantation for COPD
por: Ekström, Magnus, et al.
Publicado: (2017)

Breathlessness and opioid prescribing in COPD in general practice: a cross-sectional, observational study
por: Currow, David C., et al.
Publicado: (2020)

Burn injury during long-term oxygen therapy in Denmark and Sweden: the potential role of smoking
por: Tanash, Hanan A, et al.
Publicado: (2017)

Cause-specific mortality in individuals with severe alpha 1-antitrypsin deficiency in comparison with the general population in Sweden
por: Tanash, Hanan A, et al.
Publicado: (2016)

The Adaptation, Face, and Content Validation of a Needs Assessment Tool: Progressive Disease for People with Interstitial Lung Disease
por: Boland, Jason W., et al.
Publicado: (2016)

Breathlessness and sexual activity in older adults: the Australian Longitudinal Study of Ageing
por: Ekström, Magnus, et al.
Publicado: (2018)

VAScular and Chronic Obstructive Lung disease (VASCOL): a longitudinal study on morbidity, symptoms and quality of life among older men in Blekinge county, Sweden
por: Olsson, Max, et al.
Publicado: (2021)

Psychometric validation of the needs assessment tool: progressive disease in interstitial lung disease
por: Johnson, Miriam J, et al.
Publicado: (2018)

Is chronic breathlessness less recognised and treated compared with chronic pain? A case-based randomised controlled trial
por: Ahmadi, Zainab, et al.
Publicado: (2018)

Decreased Risk of Ischemic Heart Disease in Individuals with Severe Alpha 1-Antitrypsin Deficiency (PiZZ) in Comparison with the General Population
por: Tanash, Hanan, et al.
Publicado: (2020)

Implementation of the Needs Assessment Tool for patients with interstitial lung disease (NAT:ILD): facilitators and barriers
por: Reigada, C, et al.
Publicado: (2017)

The growing problem of co-treatment with opioids and benzodiazepines
por: Karaca-Mandic, Pinar, et al.
Publicado: (2017)

A comparison of opioids and benzodiazepines dispensing in Australia
por: Islam, M. Mofizul, et al.
Publicado: (2019)

Relating Experienced To Recalled breathlessness Observational (RETRO) study: a prospective study using a mobile phone application
por: Sandberg, Jacob, et al.
Publicado: (2019)

No gender-related bias in COPD diagnosis and treatment in Sweden: a randomised, controlled, case-based trial
por: Akbarshahi, Hamid, et al.
Publicado: (2020)

Opioid and benzodiazepine prescribing after COVID‐19 hospitalization
por: Delaney, Lia D., et al.
Publicado: (2022)

Breathlessness dimensions association with physical and mental quality of life: the population based VASCOL study of elderly men
por: Cristea, Lucas, et al.
Publicado: (2021)

Co-prescription of opioids with benzodiazepine and other co-medications among opioid users: differential in opioid doses
por: Zin, Che Suraya, et al.
Publicado: (2017)

Anhedonia modulates benzodiazepine and opioid demand among persons in treatment for opioid use disorder
por: Greenwald, Mark K., et al.
Publicado: (2023)

The effect of opioid analgesics, benzodiazepines, gabapentinoids, and opioid agonist treatment on mortality risk among opioid-dependent people.
por: Bharat, Chrianna, et al.
Publicado: (2022)

Daily duration of long-term oxygen therapy and risk of hospitalization in oxygen-dependent COPD patients
por: Sundh, Josefin, et al.
Publicado: (2018)

Prevalence and severity of differing dimensions of breathlessness among elderly males in the population
por: Olsson, Max, et al.
Publicado: (2021)

Memory function in opioid-dependent patients treated with methadone or buprenorphine along with benzodiazepine: longitudinal change in comparison to healthy individuals
por: Rapeli, Pekka, et al.
Publicado: (2009)

Implementation of an Opioid and Benzodiazepine Deprescribing Program for Older Adults in an Outpatient Setting
por: Armistead, Lori, et al.
Publicado: (2020)

Primary-Care Prescribers’ Perspectives on Deprescribing Opioids and Benzodiazepines in Older Adults
por: Niznik, Joshua D., et al.
Publicado: (2022)

Comparing recalled versus experienced symptoms of breathlessness ratings: An ecological assessment study using mobile phone technology
por: Sandberg, Jacob, et al.
Publicado: (2022)

Persisting breathlessness and activities reduced or ceased: a population study in older men
por: Kochovska, Slavica, et al.
Publicado: (2022)

REgistry-based randomized controlled trial of treatment and Duration and mortality in long-term OXygen therapy (REDOX) study protocol
por: Sundh, Josefin, et al.
Publicado: (2019)

Outpatient, combined use of opioid and benzodiazepine medications in the United States, 1993–2014
por: Hirschtritt, Matthew E., et al.
Publicado: (2017)

Anticonvulsant activity of Dorema ammoniacum gum: evidence for the involvement of benzodiazepines and opioid receptors
por: Motevalian, Manijeh, et al.
Publicado: (2017)

Association between concurrent use of prescription opioids and benzodiazepines and overdose: retrospective analysis
por: Sun, Eric C, et al.
Publicado: (2017)

Concomitant benzodiazepine and opioids decrease sleep apnoea risk in chronic pain patients
por: Mir, Soodaba, et al.
Publicado: (2020)

Opioid Safety and Concomitant Benzodiazepine Use in End-Stage Renal Disease Patients
por: Ruchi, Rupam, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_hjibu2qvsotlq1v9ieausohvc3